Thu, 14th Jan 2021 14:55
Oncimmune Holdings PLC - Nottingham, England-based early detection of cancer - Non-Executive Director Cheung To sells 195,000 shares via Genostics Co Ltd at prices ranging from GBP1.65 to GBP1.85, worth over GBP330,000, between December 11 and Monday this week. Retains 6.2 million shares, a 9.8% stake.
Current stock price: 185.60 pence
Year-to-date change: up 13%
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
(Sharecast News) - Oncimmune reported revenue of £2.1m in its final results on Thursday, down from £3.8m for the prior extended 15-month per...
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Announces plans to focus on higher value customers, penetrating key a...
Oncimmune (ONC)